comparemela.com

Latest Breaking News On - Clinton rossiter professor - Page 2 : comparemela.com

Congress and policy making 21st century | American government, politics and policy

Congress and policy making 21st century | American government, politics and policy
cambridge.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cambridge.org Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Cornell-university
Massachusetts-institute-of-technology
Massachusetts
Michigan
Harvard-university
American
Theda-skocpol
Charles-shipan
Kennetha-shepsle
R-douglas-arnold

Confusion about vaccine guidelines could prolong pandemic

April 28, 2021 Though more than 142 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the New England Journal of Medicine. In a nationally representative survey of more than 1,000 American adults conducted in February, less than half of respondents said they believed the Moderna and Pfizer-BioNTech vaccines provided strong protection against COVID-19 a week or two after a second dose, consistent with guidance from the U.S. Centers for Diseases Control and Prevention (CDC), the researchers found. One-fifth believed the vaccines provided strong protection after only one dose, and another 36% were unsure.

Boston
Massachusetts
United-states
Americans
American
Jillian-goldfarb
Johnl-wetherill
Sarah-kreps
Douglas-kriner
John-brownstein
Pfizer
Department-of-government

Study: Failure to combat second-dose vaccine attrition could prolong the pandemic

Study: Failure to combat second-dose vaccine attrition could prolong the pandemic Though more than 131 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the New England Journal of Medicine. In a nationally representative survey of more than 1,000 American adults conducted in February, less than half of respondents said they believed the Moderna and Pfizer-BioNTech vaccines provided strong protection against COVID-19 a week or two after a second dose, consistent with guidance from the U.S. Centers for Diseases Control and Prevention (CDC), the researchers found. One-fifth believed the vaccines provided strong protection after only one dose, and another 36% were unsure.

Boston
Massachusetts
United-states
Americans
American
Jillian-goldfarb
Johnl-wetherill
Sarah-kreps
Douglas-kriner
Emily-henderson
John-brownstein
Pfizer

Skipping the second shot could prolong pandemic, study finds

 E-Mail ITHACA, N.Y. - Though more than 131 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the New England Journal of Medicine. In a nationally representative survey of more than 1,000 American adults conducted in February, less than half of respondents said they believed the Moderna and Pfizer-BioNTech vaccines provided strong protection against COVID-19 a week or two after a second dose, consistent with guidance from the U.S. Centers for Diseases Control and Prevention (CDC), the researchers found. One-fifth believed the vaccines provided strong protection after only one dose, and another 36% were unsure.

Boston
Massachusetts
United-states
Americans
American
Jillian-goldfarb
Johnl-wetherill
Sarah-kreps
Douglas-kriner
John-brownstein
Pfizer
Department-of-government

Skipping second shot could prolong pandemic, study finds

Date Time Skipping second shot could prolong pandemic, study finds Though more than 131 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the New England Journal of Medicine. In a nationally representative survey of more than 1,000 American adults conducted in February, less than half of respondents said they believed the Moderna and Pfizer-BioNTech vaccines provided strong protection against COVID-19 a week or two after a second dose, consistent with guidance from the U.S. Centers for Diseases Control and Prevention (CDC), the researchers found. One-fifth believed the vaccines provided strong protection after only one dose, and another 36% were unsure.

Boston
Massachusetts
United-states
Americans
American
Jillian-goldfarb
Johnl-wetherill
Sarah-kreps
Douglas-kriner
John-brownstein
Pfizer
Department-of-government

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.